Skip to main content.

Wyeth

Picture of Martha Rosenberg

How well is the media doing its job to vet sources' ties to pharmaceutical funding? New research shows that academics who promoted the use of antiviral drugs for swine flu were eight times more likely to have financial links to drug companies.

Picture of Martha Rosenberg

 Marketed to men, testosterone is supposed to be a way to stay young and virile. Marketed to women, it is supposed to be a way to recapture waning sexual desire and boost the libido.

Picture of Martha Rosenberg

Researching, writing and submitting papers to medical journals--and reworking and finessing them if accepted--is a demanding, time consuming job which drug companies have made into pay dirt.

Picture of William Heisel

In these tough economic times, it might seem crazy to turn down a paycheck. But what if that paycheck has complicated strings attached?

 

Picture of William Heisel

Journalist Liz Scherer talks with Antidote blogger William Heisel about why we medicalize menopause and other life transitions in a wide-ranging conversation about media coverage of women's health.

Picture of William Heisel

William Heisel interviews health writer Liz Scherer about the latest coverage of the Women's Health Initiative study on hormone replacement therapy and her tips for covering women's health.

Picture of William Heisel

Fishing for a health fraud lawsuit under the False Claims Act can be complicated if you just have a suspicion that something funny is going on. Here are some tips for finding these cases in your state.

Picture of William Heisel

Adriane Fugh-Berman has been leading the charge against the use of drug company-sponsored ghostwriters to craft scientific articles for publication in seemingly legitimate journals. She has been a paid expert witness on behalf of plaintiffs in the litigation over hormone replacement therapy drugs, and she directs PharmedOut, a project at Georgetown University that aims to scrub industry influence from medical training.

Picture of William Heisel

In October, Antidote reported that Dr. John Eden, a well-respected Australian hormone researcher and the founder and director of the Sydney Menopause Centre, had second thoughts about his participation in a review article about hormone replacement therapy (HRT) that was written with the help of pharmaceutical giant Wyeth.

Pages

Announcements

Got a great idea for a reporting project on the health of underserved communities in California or on the performance of the state's health and social safety nets?  We're offering reporting grants of $2,000 to $10,000, plus six months of mentoring, to up to eight individual journalists, newsrooms or cross-newsroom collaboratives.  Deadline to apply:  September 20.

Interested in honing your data analysis and visualization skills and taking home a reporting grant of $2,000-$3,500? Dates: October 23-26. Deadline to apply: August 26. Click on the headline to learn more.

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth